|
Volumn 4, Issue 6, 2003, Pages 380-382
|
SR 58611A SR 58611
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL;
5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE;
[[7 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO] 5,6,7,8 TETRAHYDRO 2 NAPHTHYL]OXY]ACETIC ACID ETHYL ESTER;
ADRENERGIC RECEPTOR STIMULATING AGENT;
ALPRENOLOL;
BETA 3 ADRENERGIC RECEPTOR;
BUPRANOLOL;
CLENBUTEROL;
CYCLIC AMP;
DRUG METABOLITE;
FLUOXETINE;
GLYCEROL;
IMIPRAMINE;
ISOPRENALINE;
PAROXETINE;
PHENETHYL ALCOHOL;
PROPRANOLOL;
SALBUTAMOL;
SR 58878;
ARTICLE;
CLINICAL TRIAL;
DEPRESSION;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG DESIGN;
DRUG EFFICACY;
DRUG POTENCY;
DRUG TOLERABILITY;
FRANCE;
HUMAN;
INTESTINE MOTILITY;
IRRITABLE COLON;
LIPID METABOLISM;
NONHUMAN;
OBESITY;
PRIORITY JOURNAL;
TACHYCARDIA;
THERMOGENESIS;
TREATMENT INDICATION;
ANIMALS;
ANTIDEPRESSIVE AGENTS;
CLINICAL TRIALS;
DEPRESSIVE DISORDER;
GASTRIC ACID;
GASTROINTESTINAL MOTILITY;
HUMANS;
OBESITY;
RECEPTORS, ADRENERGIC, BETA-3;
TETRAHYDRONAPHTHALENES;
|
EID: 0242606145
PISSN: 11745886
EISSN: None
Source Type: Journal
DOI: 10.2165/00126839-200304060-00012 Document Type: Article |
Times cited : (3)
|
References (7)
|